Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Sep 30, 2014 (12 years ago)

Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate)

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1

Affected NDC 61958-0701-01

Compare with the code on your package — it is the most precise check available.

Drug: Emtricitabine

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Truvada
emtricitabine and tenofovir disoproxil fumarate
NDC 61958-0701
EMTRICITABINE 200 mg/1; TENOFOVIR DISOPROXIL FUMARATE 300 mg/1 Tablet, Film Coated
Oral
Gilead Sciences, Inc Rx
Recalling firm
Gilead Sciences, Inc.
NDC code
61958-0701-1
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0013-2015 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Emtricitabine recalls

See all
Class III · Low risk

Atripla

Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.

Terminated Particulate / foreign matter Gilead Sciences, Inc. NDC 15584-0101-1 D-1090-2014

Other recalls by Gilead Sciences, Inc.

All 2014 recalls
Class I · High risk

Veklury (remdesivir)

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Terminated Particulate / foreign matter Gilead Sciences, Inc. NDC 61958-2901-2 D-0299-2022
Class III · Low risk

Atripla

Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.

Terminated Particulate / foreign matter Gilead Sciences, Inc. NDC 15584-0101-1 D-1090-2014